The first shipments of Serum Institute of India (SII) Covishield coronavirus vaccine have begun to be shipped to cities in India. On Tuesday, January 12, the agency reports. PTI.
SII is Oxford’s Indian vaccine partner AstraZeneca.
The first batch of the drug was sent from Pune on a special flight to New Delhi. 478 boxes of vaccines weighing 32 kg will be delivered to the capital.
During the day, vaccine shipments will also be sent to Ahmedabad, Chennai, Kolkata, Bangalore, Karnal, Hyderabad, Vijayawada, Guwahati, Lucknow, Chandigarh and Bhubaneswar. In Mumbai, the vaccine will be delivered from Pune by specially equipped trucks that maintain the required temperature regime.
Nationwide vaccinations are reported to begin in all states of India on January 16.
On January 1, it was reported that a committee of experts from the Indian pharmaceuticals and medical devices regulator approved the emergency use of the Covishield coronavirus vaccine.
It is also planned to use the Covaxin vaccine from the Indian company Bharat Biotech. Both drugs are manufactured in India. In addition, at the end of November, RDIF and the Indian drug manufacturer Hetero signed an agreement to produce the Russian Sputnik V vaccine. Under the contract, India is supposed to produce over 100 million doses of this drug per year. The country is also preparing to begin the third phase of testing “Sputnik V”
Currently India, according to Worldometer, is in second place in the world after the United States in the number of detected cases of coronavirus. As of January 12, 10,479,913 cases of COVID-19 were detected in the country, 151,364 people died, 10,111,294 patients recovered.